PEN: Penumbra Inc Price to Sales

Symbol and logo of brand Penumbra Inc (PEN)

Penumbra, Inc. (PEN) maintains its reputation as a lifesaver in stroke treatment, bolstered by breakthrough developments in computer vision and VR rehabilitation. The revenue multiple trend visualizes the market valuation of these achievements, where the latest parameter stands at 8.10. Such a high business valuation is driven by the creation of a closed ecosystem of thrombectomy tools, making it virtually impossible for clinics to migrate to alternative systems.

PEN (Penumbra) P/S Multiple history from 07/04/2022 to 11/13/2026

Analytical breakdowns for Penumbra Corp (PEN)

- market price and analyst price targets:
Stock Quotes penumbrainc.com|PEN - Analyst Consensus Forecast
- market capitalization information:
Market Value Penumbra Corp|PEN - Enterprise Value
- shareholders' equity book value data:
Equity per Share Penumbra|PEN - Book Capitalization|Market Capitalization to Book Value penumbrainc.com|PEN - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Penumbra, Inc.|PEN - Long-Term Debt to Capital|Short-Term Debt to Capital Penumbra Medical|PEN - Company Debts|Debt to Book Capitalization Ratio Penumbra Corp|PEN - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Penumbra|Immediate Liquidity penumbrainc.com
- net income and valuation multiples indicators:
PEN - Company Net Income|Projected Net Profit Penumbra, Inc.|PEN - Price to Earnings Ratio|Forward P/E Multiple Penumbra Inc|PEN - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Penumbra Corp|PEN - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Penumbra|PEN - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months penumbrainc.com|PEN - Earnings growth in current year|Expected net earnings per share growth next year Penumbra, Inc.
- issuer revenue and sales details:
PEN - Company Revenue|Company Revenue Forecast penumbrainc.com|PEN - Market Cap to Revenue|Price to Expected Revenue Ratio Penumbra Corp
Fundamental company analysis:penumbrainc.com PEN
Original product of Penumbra Corp

Geopolitical risks and electronics supply chain disruptions leave Penumbra, Inc. (PEN) revenue vulnerable to external shocks, necessitating a thorough analysis of market expectations. The capitalization-to-revenue ratio, represented by the price-to-sales multiple, determines the value of every dollar of sales, allowing investors to assess the asset's overbought status and identify a safe entry point amidst high volatility.

Who Penumbra, Inc. competes with

Market Cap to Revenue dexcom.com DXCM|P/S Multiple NOVT (Novanta)|Haemonetics Corp (HAE) - Price to Sales|Inspire Sleep - P/S Multiple|PRCT (Procept) - Market Cap to Revenue Ratio|CNMD: P/S Multiple|PLSE - Price-to-Revenue Coefficient|INMD (InMode) - P/S Multiple|Market Cap to Revenue Picard Medical Corp (PMI)|P/S Multiple SRDX|P/S Multiple Eversense (SENS)|Price-to-Revenue Ratio NeuroPace, Inc. NPCE|Tactile Systems Technology, Inc. - Price-to-Revenue Ratio|SNWV: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio OM (Outset Medical Inc)|ELMD: P/S Multiple|Price to Sales LENSAR Inc (LNSR)|Price-to-Revenue Ratio AVITA Medical, Inc.|PROF - Price-to-Revenue Multiple|Market Cap to Revenue BDMD (Baird Medical Investment)|P/S Multiple edap-tms.com (EDAP)|P/S Multiple APYX (Apyx Medical Corporation)|Price-to-Revenue Coefficient IceCure Medical Ltd. (ICCM)|LUNG - Price-to-Revenue Ratio|Price-to-Sales Ratio TELA|cytosorbents.com (CTSO) - Price-to-Revenue Ratio|Market Cap to Revenue Sensus Healthcare Inc|ZYXI (Zynex Inc) - P/S Multiple|Price to Sales electroCore Medical ECOR|Price-to-Revenue Ratio Vicarious Surgical Inc. (RBOT)|inspira-technologies.com - Market Cap to Revenue Ratio|SeaStar Medical - Market Cap to Revenue|Market Cap to Sales Volume IRIX (IRIDEX Corp)|INBS - Price-to-Revenue Ratio|Price-to-Sales Ratio XAIR|PFSA: P/S Multiple|Price to Sales STRATA Skin Sciences, Inc. (SSKN)|Price-to-Revenue Ratio GlucoTrack, Inc.|Market Cap to Revenue Ratio NAOV (nanovibronix.com)|Market Cap to Revenue VERO (Venus Concept Corp)|P/S Multiple Nuwellis Corp (NUWE)|Price-to-Revenue Ratio Aethlon Medical AEMD|ASXC - Market Cap to Revenue|Avinger - P/S Multiple|BSGM: Price-to-Revenue Ratio|Cutera, Inc (CUTR) - Price-to-Revenue Ratio|Know Labs Corporation - Market Capitalization-to-Revenue Ratio|NARI (Inari Medical, Inc.) - P/S Multiple|P/S Multiple nevro.com|Market Cap to Revenue RSLS (ReShape Lifesciences)|SILK (Silk Road Medical, Inc.) - Market Capitalization-to-Revenue Ratio